Etiome
Cambridge
About Etiome
Etiome is disrupting the progression of disease before it becomes debilitating and irreversible by developing and deploying Biostaged Medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2025)
- Website: etiome.bio
- Phone: +1 617-868-1888
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/etiome-45640 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.